Questionnaires of Activities of Daily Living in Patients with Alzheimer Disease

Česká verzia

Authors: P. Martínek ¹; A. Bartoš- ^{1 3}
Authors place of work: AD Centrum ¹; Psychiatrické centrum Praha ²; Univerzita Karlova v Praze, 3. LF a FN Královské Vinohrady, Neurologická klinika, Praha ³
Published in the journal: Cesk Slov Neurol N 2011; 74/107(6): 632-640
Category: Review Article

Summary

The assessment of daily activities in patients with Alzheimer’s disease provides much valuable information. It may be used to distinguish between normal aging, mild cognitive impairment and dementia; to evaluate the efficacy of treatment effect or the progression of disease; for the assessment of the severity of the disease, and more. In a clinical setting, the use of structured questionnaires seems to be the best approach. To date, four scales have been translated into Czech (http://www.pcp.lf3.cuni.cz/adcentrum). The functional activities questionnaire (FAQ-CZ) is suitable for discriminating between normal aging and early dementia. The disability assessment for dementia (DAD-CZ) and the Bristol activities of daily living scale (BADLS-CZ) enable the assessment of daily activities in patients suffering from mild to severe degrees of dementia, as well the monitoring of disease progression and treatment effect. The Lawton IADL scale is widely used despite its numerous limitations, among them that it exists in several versions and its scoring can be ambiguous. We review the benefits of investigating activities of daily living and of questionnaires. We also outline certain practical recommendations tailored to suit our local conditions.

Key words:
Activities of daily living – ADL – Alzheimer’s disease – questionnaires –functional activities questionnaire –FAQ –disability assessment for dementia – DAD –Bristol activities of daily living scale – BADLS – practical recommendations – dementia

Zdroje

1. Bartoš A, Hasalíková M. Poznejte demenci správně a včas – příručka pro klinickou praxi. 1st ed. Praha: Mladá fronta 2010.

2. Rektorová I. Neurodegenerativní demence. Cesk Slov Neurol N 2009; 72/104(2): 97–109.

3. Topinková E. Zlepšení diagnózy demence v primární péči – role mezioborové spolupráce. Psychiat pro praxi 2001; 2(2): 78–83.

4. Topinková E. Jak správně a včas diagnostikovat demenci. Manuál pro klinickou praxi. Praha: UCB Pharma 1999.

5. Čechová L, Bartoš A, Doležil D, Řípová D. Alzheimerova nemoc a mírná kognitivní porucha: diagnostika a léčba. Neurologie pro praxi, 2011, 12(3): 175–180.

6. Petersen RC, Roberts RO, Knopman DS, Boeve BF, Geda YE, Ivnik RJ et al. Mild cognitive impairment: ten years later. Arch Neurol 2009; 66(12): 1447–1455.

7. Barberger-Gateau P, Fabrigoule C, Amieva H, Helmer C, Dartigues JF. The disablement process: a conceptual framework for dementia-associated disability. Dement Geriatr Cogn Disord 2002; 13(2): 60–66.

8. Aalten P, van Valen E, Clare L, Kenny G, Verhey F. Awareness in dementia: a review of clinical correlates. Aging Ment Health 2005; 9(5): 414–422.

9. Martínek P, Bartoš A. Aktivity denního života pacientů s Alzheimerovou nemocí očima jejich pečovatelů. Čes Ger Rev 2008; 6(3): 186–192.

10. Bartoš A, Martínek P, Bezdíček O, Buček A, Řípová D. Dotazník funkčního stavu FAQ-CZ – česká verze pro zhodnocení každodenních aktivit pacientů s Alzheimerovou nemocí. Psychiat pro praxi 2008; 9(1): 31–34.

11. Bartoš A, Martínek P, Buček A, Řípová D. Dotazník soběstačnosti DAD-CZ – česká verze pro hodnocení každodenních aktivit pacientů s Alzheimerovou nemocí. Neurol pro praxi 2009; 10(5): 320–323.

12. Bartoš A, Martínek P, Řípová D. Dotazník Bristolská škála aktivit denního života BADLS-CZ pro hodnocení pacientů s demencí. Cesk Slov Neurol N 2010; 73/106(6): 673–677.

13. Martínek P, Bartoš A. Dotazníky k hodnocení běžných činností u pacientů s Alzheimerovou nemocí. Psychiatrie 2010; 14(4): 175–180.

14. Martínek P. Stanovení běžných aktivit pacientů s Alzheimerovou nemocí v klinické praxi. Diplomová práce. Praha: UK 3. LF 2010.

15. Farias ST, Mungas D, Reed BR, Harvey D, Cahn--Weiner D, Decarli C. MCI is associated with deficits in everyday functioning. Alzheimer Dis Assoc Disord 2006; 20(4): 217–223.

16. Perneczky R, Pohl C, Sorg C, Hartmann J, Tosic N, Grimmer T et al. Impairment of activities of daily living requiring memory or complex reasoning as part of the MCI syndrome. Int J Geriatr Psychiatry 2006; 21(2): 158–162.

17. Amieva H, Le Goff M, Millet X, Orgogozo JM, Pérès K, Barberger-Gateau P et al. Prodromal Alzheimer‘s disease: successive emergence of the clinical symptoms. Ann Neurol 2008; 64(5): 492–498.

18. Albert MS, Dekosky ST, Dickson D, Dubois B, Feldman HH, Fox NC et al. The diagnosis of mild cognitive impairment due to Alzheimer‘s disease: recommendations from the National Institute on Aging-Alzheimer‘s Association workgroups on diagnostic guidelines for Alzheimer‘s disease. Alzheimers Dement 2011; 7(3): 270–279.

19. Tabert MH, Albert SM, Borukhova-Milov L, Camacho Y et al. Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology 2002; 58(5): 758–764.

20. Galvin JE, Roe CM, Powlishta KK, Coats MA, Muich SJ, Grant E et al. The AD8: a brief informant interview to detect dementia. Neurology 2005; 65(4): 559–564.

21. Stern Y, Albert SM, Sano M, Richards M, Miller L, Folstein M et al. Assessing patient dependence in Alzheimer‘s disease. J Gerontol 1994; 49(5): M216–M222.

22. Galasko D. An integrated approach to the management of Alzheimer‘s disease: Assessing cognition, function and behaviour. Eur J Neurol 1998; 5 (Suppl 4): S9–S17.

23. Berg L. Clinical dementia rating. Psychopharmacol Bull 1988; 24(4): 637–639.

24. McKeith IG, Cummings JL, Lovestone S, Harvey R, Wilkinson DP. Outcome measures in Alzheimer’s disease. London: Martin Dunitz 1999.

25. Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982; 139(9): 1136–1139.

26. Reisberg B. Functional Assessment Staging (FAST). Psychopharmacol Bull 1988; 24(4): 653–659.

27. Folstein MF, Folstein SE, McHugh PR. „Mini-Mental State“. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12(3): 189–198.

28. Sheardová K, Hort J, Rusina R, Bartoš A, Línek V, Ressner P, Rektorová I. Doporučené postupy pro léčbu Alzheimerovy nemoci a dalších onemocnění spojených s demencí. Cesk Slov Neurol N 2007; 70/103(5): 589–594.

29. Perneczky R, Wagenpfeil S, Komossa K, Grimmer T, Diehl J, Kurz A. Mapping scores onto stages: mini-mental state examination and clinical dementia rating. Am J Geriatr Psychiatry 2006; 14(2): 139–144.

30. Choi SH, Lee BH, Kim S, Hahm DS, Jeong JH, Yoon SJ et al. Interchanging scores between clinical dementia rating scale and global deterioration scale. Alzheimer Dis Assoc Disord 2003; 17(2): 98–105.

31. Hummelová-Fanfrdlová Z, Rektorová I, Sheardová K,Bartoš A, Línek V, Ressner P et al. Česká adaptace Addenbrookského kognitivního testu (Addenbrooke´s Cognitive Examination). Československá psychologie 2009, 4: 376–388.

32. Bartoš A, Raisová M, Kopeček M. Novelizace české verze Addenbrookského kognitivního testu (ACE-CZ). Cesk Slov Neurol N 2011; 74/107(6): 681–684.

33. Bartoš A. Zjevná afázie není přítomna ani ve středním stadiu Alzheimerovy nemoci. Cesk Slov Neurol N 2010; 73/106(3): 254–257.

34. Košťálová M, Bednařík J, Skutilová S, Mitášová A, Bártková E, Šajgalíková K et al. Afázie a její vztah k tíži kognitivního deficitu u demence. Cesk Slov Neurol N 2010; 73/106(3): 258–266

35. Teunisse S, Derix MM, van Crevel H. Assessing the severity of dementia. Patient and caregiver. Arch Neurol 1991; 48(3): 274–277.

36. Wicklund AH, Johnson N, Rademaker A, Weitner BB, Weintraub S. Profiles of decline in activities of daily living in non-Alzheimer dementia. Alzheimer Dis Assoc Disord 2007; 21(1): 8–13.

37. Mioshi E, Kipps CM, Dawson K, Mitchell J, Graham A, Hodges JR. Activities of daily living in frontotemporal dementia and Alzheimer disease. Neurology 2007; 68(24): 2077–2084.

38. Gure TR, Kabeto MU, Plassman BL, Piette JD, Langa KM. Differences in functional impairment across subtypes of dementia. J Gerontol A Biol Sci Med Sci 2010; 65(4): 434–441.

39. Lehfeld H, Erzigkeit H. Beeinträchtigungen der Alltags-aktivitäten (ADL) und der kognitiven Leistungsfähigkeit in unterschiedlichen Demenzstadien: Ein Vergleich von ADL-Fremdbeurteilungen, ADL-Selbsteinschätzungen und einem psychometrischen Leistungstest. Fortschritte der Neurologie – Psychiatrie 2000; 68(6): 262–269.

40. Bucks RS, Haworth J. Bristol Activities of Daily Living Scale: a critical evaluation. Expert Rev Neurother 2002; 2(5): 669–676.

41. Rabins PV. The caregiver‘s role in Alzheimer‘s disease. Dement Geriatr Cogn Disord 1998; 9 (Suppl 3): 25–28.

42. Razani J, Kakos B, Orieta-Barbalace C, Wong JT, Casas R, Lu P et al. Predicting caregiver burden from daily functional abilities of patients with mild dementia. J Am Geriatr Soc 2007; 55(9): 1415–1420.

43. Sikkes SA, de Lange-de Klerk ES, Pijnenburg YA, Scheltens P, Uitdehaag BM. A systematic review of Instrumental Activities of Daily Living scales in dementia: room for improvement. J Neurol Neurosurg Psychiatry 2009; 80(1): 7–12.

44. Demers L, Oremus M, Perrault A, Champoux N, Wolfson C. Review of outcome measurement instruments in Alzheimer‘s disease drug trials: psychometric properties of functional and quality of life scales. J Geriatr Psychiatry Neurol 2000; 13(4): 170–180.

45. Lindeboom R, Vermeulen M, Holman R, De Haan RJ. Activities of daily living instruments:optimizing scales for neurologic assessments. Neurology 2003; 60(5): 738–742.

46. Burns A, Lawlor B, Craig S. Assessment Scales in Old Age Psychiatry. 2nd ed. London: Martin Dunitz 2004.

47. Kalvach Z. Hodnocení soběstačnosti a výkonnosti. In: Kalvach Z et al (eds). Geriatrie a gerontologie. Praha: Grada Publishing 2004.

48. Sheardová K. Mírná kognitivní porucha v praxi. Psychiat pro praxi 2010; 11(2): 62–65.

49. Mátlová M, Holmerová I, Bartoš A. Dny paměti – jak na včasnou diagnózu Alzheimerovy choroby. Čes Ger Rev 2009; 7(3–4): 157–160.

50. Bezdíček O, Lukavský J, Preiss M. Validizační studie české verze dotazníku FAQ. Cesk Slov Neurol N 2011; 74/107(1): 36–42.

51. Juva K, Mäkelä M, Erkinjuntti T, Sulkava R, Ylikoski R, Valvanne J et al. Functional assessment scales in detecting dementia. Age Ageing 1997; 26(5): 393–400.

52. Teng E, Becker BW, Woo E, Knopman DS, Cummings JL, Lu PH. Utility of the Functional Activities Questionnaire for Distinguishing Mild Cognitive Impairment From Very Mild Alzheimer Disease. Alzheimer Dis Assoc Disord. In press 2010.

53. Feldman H, Sauter A, Donald A, Gélinas I, Gauthier S, Torfs K et al. The disability assessment for dementia scale: a 12-month study of functional ability in mild to moderate severity Alzheimer disease. Alzheimer Dis Assoc Disord 2001; 15(2): 89–95.

54. Bucks RS, Ashworth DL, Wilcock GK, Siegfried K. Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale. Age Ageing 1996; 25(2): 113–120.

55. Ressner P, Hort J, Rektorová I, Bartoš A, Rusina R, Línek V, Sheardová K. Doporučené postupy pro diagnostiku Alzheimerovy nemoci a dalších onemocnění spojených s demencí. Cesk Slov Neurol N 2008; 71/104(4): 494–501.

56. Hort J, O‘Brien JT, Gainotti G, Pirttila T, Popescu BO, Rektorova I et al. EFNS guidelines for the diagnosis and management of Alzheimer‘s disease. Eur J Neurol 2010; 17(10): 1236–1248.